RIMACTANE

This brand name is authorized in Hong Kong SAR China, Malta, South Africa, UK.

Active ingredients

The drug RIMACTANE contains one active pharmaceutical ingredient (API):

1	Rifampicin UNII VJT6J7R4TR - RIFAMPIN
	Rifampicin is an active bactericidial antituberculosis drug which is particularly active against the rapidly growing extracellular organisms and also has bactericidial activity intracellularly. Rifampicin inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme.
	Read more about Rifampicin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RIMACTANE Capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J04AB02	Rifampicin	J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AB Antibiotics
Discover more medicines within J04AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	53393
HK	Department of Health Drug Office	49222, 49223
MT	Medicines Authority	AA565/49401
ZA	Health Products Regulatory Authority	H/20.2.3/68, Q/20.2.3/29